Raymond James Lowers Viking Therapeutics, Inc. (VKTX) Price Target Amid Optimistic Clinical Initiative Outlook [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
Viking Therapeutics, Inc. (NASDAQ: VKTX ) ranks among the most shorted stocks to buy according to analysts . After the company's fourth-quarter 2025 earnings report, Raymond James maintained its Strong Buy rating on Viking Therapeutics, Inc. (NASDAQ:VKTX) but cut its price objective from $122 to $118 on February 12. The company highlighted its optimistic outlook for Viking's oral VK2735 and advanced clinical subQ initiatives in the obesity treatment market, along with its novel amylin agonist, which is expected to start clinical trials later this year. Raymond James Lowers Viking Therapeutics, Inc. (VKTX) Price Target Amid Optimistic Clinical Initiative Outlook Viking Therapeutics, Inc. (NASDAQ:VKTX) stated that it is expecting topline data from its maintenance trial and the start of the Phase 3 program for oral VK2735 in the third quarter of 2026. The company additionally wrapped up its bioequivalence research and intends to add an autoinjector VK2735 format to the VANQUISH init
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics (VKTX) was upgraded by BTIG Research to "strong-buy".MarketBeat
- Is Viking Therapeutics (VKTX) Still Attractive After Its Recent Share Price Surge [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (VKTX): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Viking Therapeutics: Full-Speed Ahead [Seeking Alpha]Seeking Alpha
VKTX
Earnings
- 2/11/26 - Miss
VKTX
Sec Filings
- 2/11/26 - Form 10-K
- 2/11/26 - Form 8-K
- 1/26/26 - Form 4
- VKTX's page on the SEC website